. 2016 Jun 29;11(2):234–239. doi: 10.1007/s12105-016-0740-7

Table 2.

Summary of previously reported cases of CTAT

References	Age/gender	Anatomic location	IHC	Metastasis status	Treatment	Outcome
Bell et al. [3]	58 M	Base of tongue	(+): CK20, CDX2, beta-catenin, CK7 (focal), MLH1, MSH2, MSH6, PMS2	Positive—1 lymph node	Surgery	No evidence of recurrence (13 months)
	58 M	Base of tongue	(+): CK20, CDX2, beta-catenin, MLH1, MSH2, MSH6, PMS2	Positive—bilateral lung nodules, multiple lymph nodes	Chemotherapy + surgery	No evidence of recurrence (11 months)
	58 M	Base of tongue	(−): CK7	Positive—bilateral lung nodules, multiple lymph nodes	Chemotherapy + surgery	No evidence of recurrence (11 months)
Slova et al. [4]	49 M	Base of tongue	(+): AE1/3, CK20, CK7, CAM5.2, CDX2, villin, EMA, p16, CEA	Positive—4/64 lymph nodes	Surgery + adjuvant radiation
McDaniel et al. [5]	60 M	Anterior tongue	(+): CDX2, CK7, CK20	Positive—bilateral cervical lymph nodes	Surgery + adjuvant chemotherapy and radiation	Recurrence of disease as lung metastases (14 months postoperative); DOD 5 years postoperation
McDaniel et al. [5]	60 M	Anterior tongue	(−): TTF-1	Positive—bilateral cervical lymph nodes	Surgery + adjuvant chemotherapy and radiation
Smith et al. (present case)	53 F	Anterior (Oral) tongue	(+): AE1/3, CK20, CDX2, SATB2, beta-catenin, MLH1, MSH2, MSH6, PMS2	Negative	Surgery + adjuvant radiation	No evidence of recurrence or metastasis (8 months)
Smith et al. (present case)	53 F	Anterior (Oral) tongue	(−): CK7	Negative	Surgery + adjuvant radiation	No evidence of recurrence or metastasis (8 months)